Monjuvi 200mg-USA (Tafasitamab Vials) 200mg/5ml

Monjuvi 200mg is a prescription medication used in combination therapy for certain blood cancers. This injectable formulation comes in 200mg vials for intravenous use. Store between 2-8°C to maintain potency and efficacy. Always follow healthcare provider guidance when using Monjuvi.

Strength

200mg/5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Morphosys US Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Monjuvi 200mg is used to treat adults with relapsed or refractory diffuse large B-cell lymphoma. It works alongside other cancer therapies to target specific proteins on cancer cells. This medication is typically prescribed when other treatments have not been effective. Patients should discuss their full medical history with their healthcare provider before starting Monjuvi.

Side Effects

Monjuvi may cause infusion-related reactions during administration, including fever, chills, or difficulty breathing. Some patients experience fatigue, nausea, or cough while receiving treatment. These effects are generally temporary and monitored by healthcare professionals. Regular check-ups help track how the body responds to Monjuvi.

Precautions & Warnings

Keep Monjuvi vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vials. Use within the specified time after preparation as directed by a healthcare provider. Patients with infections or weakened immune systems should inform their doctor before starting Monjuvi.

Avoid Interactions

Monjuvi may interact with other medications that affect the immune system, including steroids or chemotherapy drugs. Live vaccines should be avoided during treatment due to potential risks. Always inform your healthcare provider about all medications, supplements, and herbal products you are using. Alcohol consumption may affect treatment tolerance.

References

Frequently Asked Questions

Monjuvi 200mg is used to treat adults with relapsed or refractory diffuse large B-cell lymphoma in combination with other cancer therapies.

Monjuvi is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects include infusion reactions, fatigue, nausea, and cough, which are typically monitored during treatment.

No, Monjuvi must be refrigerated between 2-8°C and protected from light at all times.

Yes, it may interact with immune system medications and live vaccines; always inform your doctor about all treatments.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.